Export Snapshot

Minimum order

1 unit

HSN Code

On request

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Standard export packaging

Shelf life / storage

As per product specification

Export markets served

Global markets

Ability to customise

As per OEM brief

Values shown are for Indiglobal Exports.

Company Indiglobal Exports

Indiglobal Exports

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Medical Equipment & Supplies.

FIEO Registered

View profile →

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

Member since

Apr 2024

Turnover

$50,000 - $250,000

Incorporation type

On request

IEC Certificate GST Certificate UDYAM Registration Certificate Certificate course in International trade-from FIEO FASSAI License Drug License

Product details

Product Overview

Gliclazide Modified-release Tablets 60 mg is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by Indiglobal Exports.

60 mg per tablet

Modified-release tablets for sustained drug delivery

Management of diabetes mellitus (Type 2 diabetes)

WHO-GMP compliant manufacturing facilities

Export-quality blister or strip packs suitable for bulk and institutional supply

Adheres to IP/USP pharmacopoeial quality benchmarks

IndiGlobal Exports

As per international regulatory standards

Hospitals, retail pharmacies, and regulated export markets

Specifications

Active Ingredient

Gliclazide

Strength per Tablet

60 mg

Dosage Form

Modified-release Tablet

Therapeutic Class

Antidiabetic agent

Packaging Type

Blister or strip packs

Compliance Standards

WHO-GMP, IP/USP quality standards

Shelf Life

As per regulatory guidelines, typically 24 months

Intended Markets

International export including regulated and semi-regulated pharmaceutical markets

Manufacturer

IndiGlobal Exports

Use cases

Category

Pharmaceuticals > Diabetes Care > Antidiabetic Medications > Oral Antidiabetic Drugs

Primary application

Brand

indiglobal exports

Product type

Product

Logistics & handling

Lead time

On request

Packaging

As per buyer requirement

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Indiglobal Exports

Minimum order

1 unit

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

What is the advantage of the modified-release formulation of Gliclazide 60 mg tablets?

The modified-release formulation ensures a controlled and sustained release of Gliclazide over time, which helps in maintaining stable blood glucose levels and reduces the frequency of dosing, thereby enhancing patient adherence.

Are these Gliclazide tablets suitable for export to international regulated markets?

Yes, these tablets are manufactured under WHO-GMP compliance and meet IP/USP pharmacopoeial standards, making them suitable for export to both regulated and semi-regulated international pharmaceutical markets.

What packaging options are available for these Gliclazide Modified-release tablets?

The product is typically available in export-quality blister or strip packs designed for bulk supply to hospitals, pharmacies, and institutional clients.

Who is the manufacturer of these Gliclazide Modified-release Tablets 60 mg?

IndiGlobal Exports is the reputable manufacturer producing these tablets in GMP-compliant facilities with stringent quality control.

What is the shelf life of the Gliclazide Modified-release Tablets 60 mg?

The shelf life is as per international regulatory standards, commonly around 24 months, ensuring product stability and efficacy throughout its usage period.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

surbhi herbal tea - an ayurvedic formulation

Hetha

From $ 5.44

MOQ 1 unit

brahmi ghrita nasal drop

Hetha

From $ 5.10

MOQ 1 unit

himalayan badri gaumutra (gomutra) ark

Hetha

From $ 3.97

MOQ 1 unit

triphala gaumutra ark

Hetha

From $ 3.97

MOQ 1 unit

desi cow gaumutra ark / gomutra ark

Hetha

From $ 3.40

MOQ 1 unit

parijat aloevera gaumutra ark

Hetha

From $ 3.97

MOQ 1 unit

kachnar gaumutra ark

Hetha

From $ 3.97

MOQ 1 unit

tulsi giloy gaumutra ark

Hetha

From $ 3.97

MOQ 1 unit

More from Indiglobal Exports

More from indiglobal exports